// COMPANY
Vivacta Bio
SECTOR BIOTECHMENTIONS 1LAST SEEN MAY 1, 2026
// OVERVIEW
Shanghai-based in-vivo cell therapy company developing treatments that genetically modify immune cells inside the body to treat cancer.
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
AI-extracted from podcast / newsletter / paper summaries. May contain errors.